These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

832 related items for PubMed ID: 8725705

  • 1. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
    Kaunitz AM.
    J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL, Peterson HB.
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [Abstract] [Full Text] [Related]

  • 5. Long-term use of hormonal contraceptive DMPA not linked to breast cancer.
    Prog Hum Reprod Res; 1995 Jan; (33):5. PubMed ID: 12289977
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Contraception and the big "C".
    Chandran R.
    Malays J Reprod Health; 1992 Jun; 10(1):1-5. PubMed ID: 12345024
    [Abstract] [Full Text] [Related]

  • 8. Breast cancer and depot-medroxyprogesterone acetate. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Thomas DB, Noonan L, Whitehead A.
    Bull World Health Organ; 1985 Jun; 63(3):513-9. PubMed ID: 2931206
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes.
    Westhoff C.
    J Reprod Med; 1996 May; 41(5 Suppl):401-6. PubMed ID: 8725702
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
    Polaneczky M, Guarnaccia M, Alon J, Wiley J.
    Fam Plann Perspect; 1996 May; 28(4):174-8. PubMed ID: 8853283
    [Abstract] [Full Text] [Related]

  • 16. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception.
    Nelson AL.
    J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701
    [Abstract] [Full Text] [Related]

  • 17. Neoplastic effects of oral contraceptives.
    Grimes DA.
    Int J Fertil; 1991 May; 36 Suppl 1():19-24. PubMed ID: 1678377
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.